Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • Crelate Reviews & Ratings
    4.5 out of 5 stars 699 Ratings
    Company Website for Crelate
  • RemotePeople Reviews & Ratings
    4.6 out of 5 stars 986 Ratings
    Company Website for RemotePeople
  • Datasite Diligence Virtual Data Room Reviews & Ratings
    4.6 out of 5 stars 738 Ratings
    Company Website for Datasite Diligence Virtual Data Room
  • ChatD&B Reviews & Ratings
    Company Website for ChatD&B
  • GWI Reviews & Ratings
    4.4 out of 5 stars 201 Ratings
    Company Website for GWI
  • Mortgage Automator Reviews & Ratings
    4.9 out of 5 stars 198 Ratings
    Company Website for Mortgage Automator
  • QUODD Reviews & Ratings
    5.0 out of 5 stars 1 Rating
    Company Website for QUODD
  • Ansarada Reviews & Ratings
    4.6 out of 5 stars 363 Ratings
    Company Website for Ansarada
  • D&B Credit Insights Reviews & Ratings
    4.2 out of 5 stars 70 Ratings
    Company Website for D&B Credit Insights
  • D&B Hoovers Reviews & Ratings
    4.1 out of 5 stars 1,299 Ratings
    Company Website for D&B Hoovers

What is Gain?

Gain is a powerful private markets intelligence platform designed to help financial professionals make better investment and deal-making decisions. It combines data, analytics, and AI into a single integrated platform that supports sourcing, research, and execution workflows. The platform offers investment-grade intelligence with extensive coverage of companies, investors, deals, and advisors across global private markets. Gain’s interconnected data graph allows users to analyze relationships and uncover opportunities more effectively. With access to hundreds of thousands of deals and thousands of investors, users can gain a comprehensive view of the market landscape. The platform enables fast sector screening, helping dealmakers identify high-potential opportunities in less time. Gain replaces multiple point solutions by consolidating tools into one streamlined system, improving efficiency and reducing complexity. It also provides proprietary insights, research reports, and industry analysis to support informed decision-making. Trusted by private equity firms, M&A advisors, consultants, and corporate teams, Gain is widely adopted across the financial industry. Its AI-powered capabilities enhance data accuracy and provide deeper insights into market trends and performance. The platform is designed to support large-scale operations and complex deal workflows. Overall, Gain helps organizations navigate private markets with confidence by delivering accurate, connected, and actionable intelligence.

What is BioSniper?

BioSniper is a research platform specifically designed for equity analysts, investors, and professionals operating within the life sciences industry. It allows users to express their research or investment concepts in clear and simple terms, which the platform then organizes into a structured workflow that incorporates a variety of screenings, evaluations by expert agents, scoring systems, blocking mechanisms, and evidence gates. The platform performs searches across seven distinct categories of public resources, including SEC EDGAR filings, insider trading information, FDA-related events, ClinicalTrials.gov, PubMed, USPTO and Google Patents, biotech news, and market analytics. Findings are meticulously linked to their source records, and any inconsistencies or missing evidence are noted as unknown, avoiding presumptions; it also presents the source and relevant dates when possible. Additionally, BioSniper features a free public calendar for biotech events, an SEC cash runway calculator, and an open-source Python toolkit that users can utilize. Beyond these functionalities, the platform strives to improve the decision-making capabilities of its users by providing extensive access to pertinent data and insights. By continuously evolving, BioSniper positions itself as an indispensable resource for informed decision-making in the dynamic life sciences field.

Media

Media

No images available

Integrations Supported

Additional information not provided

Integrations Supported

Additional information not provided

API Availability

API Availability

Pricing Information

Pricing not provided
Free Trial Offered?

Pricing Information

$39/month
A free plan is available. Researcher costs $39/month, and Analyst costs $79/month. Monthly AI credit allowances are 200, 3,000, and 10,000 for Free, Researcher, and Analyst, respectively; the plans also differ in research and customization features.
Free Version

Supported Platforms

SaaS

Supported Platforms

SaaS

Customer Service / Support

Web-Based Support

Customer Service / Support

Web-Based Support

Training Options

Documentation Hub
Webinars
Online Training

Training Options

Documentation Hub

Company Facts

Organization Name

Gain

Date Founded

2018

Company Location

United States

Company Website

www.gain.ai/

Company Facts

Organization Name

BioSniper

Date Founded

2024

Company Location

United States

Company Website

biosniper.co

Categories and Features

Deal Sourcing

Not specified

Executive Search

Not specified

Financial Research

Not specified

Market Intelligence

Not specified

Categories and Features

Financial Research

Not specified

Popular Alternatives

Popular Alternatives

PitchBook Reviews & Ratings

PitchBook

3.0 out of 5 stars
Sniper AI Reviews & Ratings

Sniper AI

Recruitment Smart Technologies
AgenticPM Reviews & Ratings

AgenticPM

Agentic Private Markets
VerityRMS Reviews & Ratings

VerityRMS

Verity